Alzamend Neuro Inc (ALZN)
Alzamend Neuros Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC
Alzamend Neuros Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC
In the priciest markets, saving and breaking even on a home purchase can take a buyer into their retirement years
Innovative Eyewear, Inc. Announces Major New AI and News Features for Lucyd App
Siebert Partners with tZERO to Give Access to Digital Securities to Its Customers
American Gold & Copper Inc. (OTC: AGCI) Signs Non-Binding Letter of Intent to Acquire Shamrock Nickel-Copper Project from Homeland Nickel Inc.
Franklin Templeton Announces Closing of Inaugural US$1.5 Billion Collateralized Fund Obligation
Corteva Announces Early Tender Results and Extension of Expiration Date in Private Exchange Offers and Consent Solicitations for EIDPs 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
Saputo inc. annonce une augmentation de son offre publique de rachat dans le cours normal des activités
Shoppers Foundation for Women’s Health™ invests $600K in 15 community partners across Canada